By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Swedish Orphan Biovitrum 

SE-112

  76 Stockholm    Sweden
Phone: 46-8-697-20-00 Fax: n/a


SEARCH JOBS


Industry
Pharmaceutical






Company News
Swedish Orphan Biovitrum Exercises Opt-In Right For Alprolix 7/16/2015 9:59:07 AM
Swedish Orphan Biovitrum Publishes Its Report For The Second Quarter 2015 - Raises Guidance 7/16/2015 9:47:51 AM
Swedish Orphan Biovitrum Release: European Commission (EC) Approves Orfadin Oral Suspension 6/29/2015 10:32:52 AM
Swedish Orphan Biovitrum Release: New Haemophilia Data At ISTH Congress To Highlight Extension Study Outcomes And Paediatric Use 6/18/2015 10:11:58 AM
Swedish Orphan Biovitrum Board Of Directors Terminates Discussions Regarding Non-Binding Proposal 6/8/2015 9:08:15 AM
Swedish Orphan Biovitrum's Partner Biogen (BIIB) Submits Marketing Authorisation Application For Alprolix (Rfixfc) In Europe 6/4/2015 8:47:23 AM
Swedish Orphan Biovitrum Receives Orphan Drug Designation For Elocta In Switzerland 4/14/2015 9:30:46 AM
Swedish Orphan Biovitrum's Xiapex Receives Positive Opinion By CHMP For The Treatment Of Peyronie's Disease 12/22/2014 12:54:20 PM
Swedish Orphan Biovitrum Awarded Company Of The Year At The European Mediscience Awards 2014 7/1/2014 9:27:19 AM
Swedish Orphan Biovitrum Establishes North American Office In Massachusetts 6/5/2014 9:33:21 AM
12345678
//-->